$THOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Synthorx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Synthorx, Inc.. Get notifications about new insider transactions in Synthorx, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 24 2020 | THOR | Synthorx, Inc. | Thompson Peter A. | Director | Option Exercise | D | 12.40 | 15,335 | 190,154 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Thompson Peter A. | Director | Option Exercise | D | 11.00 | 30,000 | 330,000 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Thompson Peter A. | Director | Sell | U | 68.00 | 5,316,355 | 361,512,140 | 0 | 5.3 M to 0 (-100.00 %) |
Jan 24 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Option Exercise | D | 11.00 | 385,185 | 4,237,035 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Option Exercise | D | 0.63 | 172,264 | 108,526 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Option Exercise | D | 0.93 | 293,177 | 272,655 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Sell | U | 68.00 | 25,000 | 1,700,000 | 0 | 25 K to 0 (-100.00 %) |
Jan 24 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Sell | U | 68.00 | 220,595 | 15,000,460 | 0 | 220.6 K to 0 (-100.00 %) |
Jan 24 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Gift | G | 0.00 | 80,706 | 0 | 215,595 | 296.3 K to 215.6 K (-27.24 %) |
Jan 24 2020 | THOR | Synthorx, Inc. | Shah Pratik | Director | Option Exercise | D | 12.40 | 10,223 | 126,765 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Shah Pratik | Director | Sell | U | 68.00 | 62,412 | 4,244,016 | 0 | 62.4 K to 0 (-100.00 %) |
Jan 24 2020 | THOR | Synthorx, Inc. | Reardon Tighe | Acting Chief Financ ... | Option Exercise | D | 11.00 | 30,000 | 330,000 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Reardon Tighe | Acting Chief Financ ... | Option Exercise | D | 4.64 | 18,723 | 86,875 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Reardon Tighe | Acting Chief Financ ... | Sell | U | 68.00 | 1,682,086 | 114,381,848 | 0 | 1.7 M to 0 (-100.00 %) |
Jan 24 2020 | THOR | Synthorx, Inc. | Reardon Tighe | Acting Chief Financ ... | Sell | U | 68.00 | 43,688 | 2,970,784 | 0 | 43.7 K to 0 (-100.00 %) |
Jan 24 2020 | THOR | Synthorx, Inc. | Powell Andrew Kenneth William | Director | Option Exercise | D | 12.40 | 6,389 | 79,224 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Powell Andrew Kenneth William | Director | Option Exercise | D | 14.00 | 27,015 | 378,210 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Milla Marcos | Chief Scientific Of ... | Option Exercise | D | 11.00 | 125,000 | 1,375,000 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Milla Marcos | Chief Scientific Of ... | Option Exercise | D | 0.93 | 227,806 | 211,860 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Milla Marcos | Chief Scientific Of ... | Option Exercise | D | 0.63 | 89,237 | 56,219 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Milla Marcos | Chief Scientific Of ... | Sell | U | 68.00 | 63,989 | 4,351,252 | 0 | 64 K to 0 (-100.00 %) |
Jan 24 2020 | THOR | Synthorx, Inc. | Lichter Jay | Director | Option Exercise | D | 12.40 | 15,335 | 190,154 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Lichter Jay | Director | Option Exercise | D | 11.00 | 30,000 | 330,000 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Lichter Jay | Director | Sell | U | 68.00 | 1,682,086 | 114,381,848 | 0 | 1.7 M to 0 (-100.00 %) |
Jan 24 2020 | THOR | Synthorx, Inc. | Lichter Jay | Director | Sell | U | 68.00 | 448,567 | 30,502,556 | 0 | 448.6 K to 0 (-100.00 %) |
Jan 24 2020 | THOR | Synthorx, Inc. | Lichter Jay | Director | Sell | U | 68.00 | 150,000 | 10,200,000 | 0 | 150 K to 0 (-100.00 %) |
Jan 24 2020 | THOR | Synthorx, Inc. | Leveque Joseph | Chief Medical Offic ... | Option Exercise | D | 11.00 | 42,000 | 462,000 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Leveque Joseph | Chief Medical Offic ... | Sell | U | 68.00 | 316,164 | 21,499,152 | 0 | 316.2 K to 0 (-100.00 %) |
Jan 24 2020 | THOR | Synthorx, Inc. | Kolchinsky Peter | Director | Option Exercise | D | 12.40 | 15,335 | 190,154 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Kolchinsky Peter | Director | Option Exercise | D | 11.00 | 30,000 | 330,000 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | Kolchinsky Peter | Director | Sell | U | 68.00 | 9,724,598 | 661,272,664 | 0 | 9.7 M to 0 (-100.00 %) |
Jan 24 2020 | THOR | Synthorx, Inc. | CAPPS VICKIE L | Director | Option Exercise | D | 12.40 | 15,335 | 190,154 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | CAPPS VICKIE L | Director | Option Exercise | D | 0.93 | 62,412 | 58,043 | 0 | |
Jan 24 2020 | THOR | Synthorx, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | U | 68.00 | 9,724,598 | 661,272,664 | 0 | 9.7 M to 0 (-100.00 %) |
Jan 16 2020 | THOR | Synthorx, Inc. | Lichter Jay | Director | Buy | J | 0.00 | 448,567 | 0 | 448,567 | 0 to 448.6 K |
Jan 16 2020 | THOR | Synthorx, Inc. | Lichter Jay | Director | Sell | J | 0.00 | 4,598,796 | 0 | 150,000 | 4.7 M to 150 K (-96.84 %) |
Jan 16 2020 | THOR | Synthorx, Inc. | Avalon Ventures X, L.P. | 10% Owner | Sell | J | 0.00 | 4,598,796 | 0 | 150,000 | 4.7 M to 150 K (-96.84 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Leveque Joseph | Chief Medical Offic ... | Option Exercise | M | 11.00 | 75,000 | 825,000 | 42,000 | |
Jan 02 2020 | THOR | Synthorx, Inc. | Leveque Joseph | Chief Medical Offic ... | Payment of Exercise | F | 70.63 | 45,019 | 3,179,692 | 313,891 | 358.9 K to 313.9 K (-12.54 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Leveque Joseph | Chief Medical Offic ... | Buy | M | 11.00 | 75,000 | 825,000 | 358,910 | 283.9 K to 358.9 K (+26.42 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Milla Marcos | Chief Scientific Of ... | Option Exercise | M | 0.63 | 98,000 | 61,740 | 89,237 | |
Jan 02 2020 | THOR | Synthorx, Inc. | Milla Marcos | Chief Scientific Of ... | Payment of Exercise | F | 70.63 | 52,011 | 3,673,537 | 63,989 | 116 K to 64 K (-44.84 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Milla Marcos | Chief Scientific Of ... | Buy | M | 0.63 | 98,000 | 61,740 | 116,000 | 18 K to 116 K (+544.44 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Option Exercise | M | 11.00 | 120,815 | 1,328,965 | 385,185 | |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Option Exercise | M | 0.63 | 147,264 | 92,776 | 172,264 | |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Option Exercise | M | 0.93 | 12,912 | 12,008 | 0 | |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Option Exercise | M | 0.93 | 98,462 | 91,570 | 293,177 | |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Payment of Exercise | F | 70.63 | 210,010 | 14,833,006 | 296,301 | 506.3 K to 296.3 K (-41.48 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Buy | M | 11.00 | 120,815 | 1,328,965 | 506,311 | 385.5 K to 506.3 K (+31.34 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Buy | M | 0.63 | 147,264 | 92,776 | 385,496 | 238.2 K to 385.5 K (+61.82 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Buy | M | 0.93 | 12,912 | 12,008 | 238,232 | 225.3 K to 238.2 K (+5.73 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Buy | M | 0.93 | 98,462 | 91,570 | 225,320 | 126.9 K to 225.3 K (+77.62 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Leveque Joseph | Chief Medical Offic ... | Option Exercise | M | 11.00 | 75,000 | 825,000 | 42,000 | |
Jan 02 2020 | THOR | Synthorx, Inc. | Leveque Joseph | Chief Medical Offic ... | Payment of Exercise | F | 70.63 | 45,019 | 3,179,692 | 313,891 | 358.9 K to 313.9 K (-12.54 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Leveque Joseph | Chief Medical Offic ... | Buy | M | 11.00 | 75,000 | 825,000 | 358,910 | 283.9 K to 358.9 K (+26.42 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Milla Marcos | Chief Scientific Of ... | Option Exercise | M | 0.63 | 98,000 | 61,740 | 89,237 | |
Jan 02 2020 | THOR | Synthorx, Inc. | Milla Marcos | Chief Scientific Of ... | Payment of Exercise | F | 70.63 | 52,011 | 3,673,537 | 63,989 | 116 K to 64 K (-44.84 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Milla Marcos | Chief Scientific Of ... | Buy | M | 0.63 | 98,000 | 61,740 | 116,000 | 18 K to 116 K (+544.44 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Option Exercise | M | 11.00 | 120,815 | 1,328,965 | 385,185 | |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Option Exercise | M | 0.63 | 147,264 | 92,776 | 172,264 | |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Option Exercise | M | 0.93 | 12,912 | 12,008 | 0 | |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Option Exercise | M | 0.93 | 98,462 | 91,570 | 293,177 | |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Payment of Exercise | F | 70.63 | 210,010 | 14,833,006 | 296,301 | 506.3 K to 296.3 K (-41.48 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Buy | M | 11.00 | 120,815 | 1,328,965 | 506,311 | 385.5 K to 506.3 K (+31.34 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Buy | M | 0.63 | 147,264 | 92,776 | 385,496 | 238.2 K to 385.5 K (+61.82 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Buy | M | 0.93 | 12,912 | 12,008 | 238,232 | 225.3 K to 238.2 K (+5.73 %) |
Jan 02 2020 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Buy | M | 0.93 | 98,462 | 91,570 | 225,320 | 126.9 K to 225.3 K (+77.62 %) |
Dec 19 2019 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Grant | A | 0.00 | 45,000 | 0 | 126,858 | 81.9 K to 126.9 K (+54.97 %) |
Dec 19 2019 | THOR | Synthorx, Inc. | Milla Marcos | Chief Scientific Of ... | Grant | A | 0.00 | 18,000 | 0 | 18,000 | 0 to 18 K |
Dec 19 2019 | THOR | Synthorx, Inc. | Leveque Joseph | Chief Medical Offic ... | Grant | A | 0.00 | 20,000 | 0 | 283,910 | 263.9 K to 283.9 K (+7.58 %) |
Jun 11 2019 | THOR | Synthorx, Inc. | Kolchinsky Peter | Director | Option Exercise | A | 12.40 | 15,335 | 190,154 | 15,335 | |
Jun 10 2019 | THOR | Synthorx, Inc. | Lichter Jay | Director | Option Exercise | A | 12.40 | 15,335 | 190,154 | 15,335 | |
Jun 10 2019 | THOR | Synthorx, Inc. | Powell Andrew Kenneth William | Director | Option Exercise | A | 12.40 | 6,389 | 79,224 | 6,389 | |
Jun 10 2019 | THOR | Synthorx, Inc. | Thompson Peter A. | Director | Option Exercise | A | 12.40 | 15,335 | 190,154 | 15,335 | |
Jun 10 2019 | THOR | Synthorx, Inc. | Romesberg Floyd | Director | Option Exercise | A | 12.40 | 15,335 | 190,154 | 15,335 | |
Jun 10 2019 | THOR | Synthorx, Inc. | CAPPS VICKIE L | Director | Option Exercise | A | 12.40 | 15,335 | 190,154 | 15,335 | |
Jun 10 2019 | THOR | Synthorx, Inc. | Shah Pratik | Director | Option Exercise | A | 12.40 | 10,223 | 126,765 | 10,223 | |
Jan 25 2019 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Option Exercise | M | 0.63 | 25,000 | 15,750 | 319,528 | |
Jan 25 2019 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Buy | M | 0.63 | 25,000 | 15,750 | 25,000 | 0 to 25 K |
Dec 21 2018 | THOR | Synthorx, Inc. | Powell Andrew Kenneth William | Director | Option Exercise | A | 14.00 | 27,015 | 378,210 | 27,015 | |
Dec 13 2018 | THOR | Synthorx, Inc. | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 6,333,206 | 0 | 0 | |
Dec 13 2018 | THOR | Synthorx, Inc. | Thompson Peter A. | Director | Buy | P | 11.00 | 1,363,636 | 14,999,996 | 5,316,355 | 4 M to 5.3 M (+34.50 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | Thompson Peter A. | Director | Buy | C | 0.00 | 3,952,719 | 0 | 3,952,719 | 0 to 4 M |
Dec 13 2018 | THOR | Synthorx, Inc. | Reardon Tighe | Acting Chief Financ ... | Option Exercise | C | 0.00 | 1,821,156 | 0 | 0 | |
Dec 13 2018 | THOR | Synthorx, Inc. | Reardon Tighe | Acting Chief Financ ... | Buy | P | 11.00 | 545,455 | 6,000,005 | 1,682,086 | 1.1 M to 1.7 M (+47.99 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | Reardon Tighe | Acting Chief Financ ... | Buy | C | 0.00 | 1,136,631 | 0 | 1,136,631 | 0 to 1.1 M |
Dec 13 2018 | THOR | Synthorx, Inc. | Lichter Jay | Director | Option Exercise | C | 0.00 | 1,821,156 | 0 | 0 | |
Dec 13 2018 | THOR | Synthorx, Inc. | Lichter Jay | Director | Option Exercise | C | 0.00 | 4,033,283 | 0 | 0 | |
Dec 13 2018 | THOR | Synthorx, Inc. | Lichter Jay | Director | Option Exercise | C | 0.00 | 1,221,896 | 0 | 0 | |
Dec 13 2018 | THOR | Synthorx, Inc. | Lichter Jay | Director | Option Exercise | C | 0.00 | 2,053,534 | 0 | 0 | |
Dec 13 2018 | THOR | Synthorx, Inc. | Lichter Jay | Director | Buy | P | 11.00 | 545,455 | 6,000,005 | 1,682,086 | 1.1 M to 1.7 M (+47.99 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | Lichter Jay | Director | Buy | C | 0.00 | 1,136,631 | 0 | 1,136,631 | 0 to 1.1 M |
Dec 13 2018 | THOR | Synthorx, Inc. | Lichter Jay | Director | Buy | C | 0.00 | 2,517,278 | 0 | 4,748,796 | 2.2 M to 4.7 M (+112.81 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | Lichter Jay | Director | Buy | C | 0.00 | 762,617 | 0 | 2,231,518 | 1.5 M to 2.2 M (+51.92 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | Lichter Jay | Director | Buy | C | 0.00 | 1,281,664 | 0 | 1,468,901 | 187.2 K to 1.5 M (+684.51 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 6,333,206 | 0 | 0 | |
Dec 13 2018 | THOR | Synthorx, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 3,952,719 | 0 | 5,316,355 | 1.4 M to 5.3 M (+289.87 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 11.00 | 1,363,636 | 14,999,996 | 1,363,636 | 0 to 1.4 M |
Dec 13 2018 | THOR | Synthorx, Inc. | Kolchinsky Peter | Director | Option Exercise | C | 0.00 | 5,854,439 | 0 | 0 | |
Dec 13 2018 | THOR | Synthorx, Inc. | Kolchinsky Peter | Director | Option Exercise | C | 0.00 | 2,443,794 | 0 | 0 | |
Dec 13 2018 | THOR | Synthorx, Inc. | Kolchinsky Peter | Director | Buy | P | 11.00 | 4,545,455 | 50,000,005 | 9,724,598 | 5.2 M to 9.7 M (+87.76 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | Kolchinsky Peter | Director | Buy | C | 0.00 | 3,653,908 | 0 | 5,179,143 | 1.5 M to 5.2 M (+239.56 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | Kolchinsky Peter | Director | Buy | C | 0.00 | 1,525,235 | 0 | 1,525,235 | 0 to 1.5 M |
Dec 13 2018 | THOR | Synthorx, Inc. | Avalon Ventures X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,821,156 | 0 | 0 | |
Dec 13 2018 | THOR | Synthorx, Inc. | Avalon Ventures X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,033,283 | 0 | 0 | |
Dec 13 2018 | THOR | Synthorx, Inc. | Avalon Ventures X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,221,896 | 0 | 0 | |
Dec 13 2018 | THOR | Synthorx, Inc. | Avalon Ventures X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,053,534 | 0 | 0 | |
Dec 13 2018 | THOR | Synthorx, Inc. | Avalon Ventures X, L.P. | 10% Owner | Buy | P | 11.00 | 545,455 | 6,000,005 | 1,682,086 | 1.1 M to 1.7 M (+47.99 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | Avalon Ventures X, L.P. | 10% Owner | Buy | C | 0.00 | 1,136,631 | 0 | 1,136,631 | 0 to 1.1 M |
Dec 13 2018 | THOR | Synthorx, Inc. | Avalon Ventures X, L.P. | 10% Owner | Buy | C | 0.00 | 2,517,278 | 0 | 4,748,796 | 2.2 M to 4.7 M (+112.81 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | Avalon Ventures X, L.P. | 10% Owner | Buy | C | 0.00 | 762,617 | 0 | 2,231,518 | 1.5 M to 2.2 M (+51.92 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | Avalon Ventures X, L.P. | 10% Owner | Buy | C | 0.00 | 1,281,664 | 0 | 1,468,901 | 187.2 K to 1.5 M (+684.51 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Option Exercise | C | 0.00 | 5,854,439 | 0 | 0 | |
Dec 13 2018 | THOR | Synthorx, Inc. | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,443,794 | 0 | 0 | |
Dec 13 2018 | THOR | Synthorx, Inc. | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 11.00 | 4,545,455 | 50,000,005 | 9,724,598 | 5.2 M to 9.7 M (+87.76 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | C | 0.00 | 3,653,908 | 0 | 5,179,143 | 1.5 M to 5.2 M (+239.56 %) |
Dec 13 2018 | THOR | Synthorx, Inc. | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | C | 0.00 | 1,525,235 | 0 | 1,525,235 | 0 to 1.5 M |
Dec 07 2018 | THOR | Synthorx, Inc. | Romesberg Floyd | Director | Option Exercise | A | 11.00 | 30,000 | 330,000 | 30,000 | |
Dec 07 2018 | THOR | Synthorx, Inc. | Thompson Peter A. | Director | Option Exercise | A | 11.00 | 30,000 | 330,000 | 30,000 | |
Dec 07 2018 | THOR | Synthorx, Inc. | Lichter Jay | Director | Option Exercise | A | 11.00 | 30,000 | 330,000 | 30,000 | |
Dec 07 2018 | THOR | Synthorx, Inc. | Reardon Tighe | Acting Chief Financ ... | Option Exercise | A | 11.00 | 30,000 | 330,000 | 30,000 | |
Dec 07 2018 | THOR | Synthorx, Inc. | Leveque Joseph | Chief Medical Offic ... | Option Exercise | A | 11.00 | 117,000 | 1,287,000 | 117,000 | |
Dec 07 2018 | THOR | Synthorx, Inc. | Milla Marcos | Chief Scientific Of ... | Option Exercise | A | 11.00 | 125,000 | 1,375,000 | 125,000 | |
Dec 07 2018 | THOR | Synthorx, Inc. | Shawver Laura | President and CEO | Option Exercise | A | 11.00 | 506,000 | 5,566,000 | 506,000 | |
Dec 07 2018 | THOR | Synthorx, Inc. | Kolchinsky Peter | Director | Option Exercise | A | 11.00 | 30,000 | 330,000 | 30,000 |
Page: 1